Tag Archives | Multiple sclerosis (MS)

Biotech Momentum Is Boosted by Biogen’s Alzheimer Disease Drug Results

Biotech Momentum Boosted by Biogen’s Experimental Drug Biogen Has an Interesting  Pipeline of Medicines for Serious Neurological Diseases Broad Biotech Rally-Green Screen Day- Even Large Caps Biotech momentum picked up on Friday after a brief sell-off in late June. Rally is just short of hitting new 2018 highs in the sector. Biotech stocks  rallied with […]

Continue Reading 0

Biotechs Get a Turbo Boost from Biogen(BIIB)…Update-1 GILD

Update-1… Gilead Sciences (GILD) Sells Off on earnings Gilead Sciences (GILD) sold off over 4% after hours after releasing second quarter sales of $7.7B and earnings of $3.08/sh. Q2 profit forecast beat. The full year revenue forecast was also cut slightly by $1B to the $29,5B-$31.5B range. Pricing pressures continued on Hep-C drugs and new […]

Continue Reading 0

Tech Hot Biotech Not: ALXN,BIIB…Update 4/26

Can Biotech Leadership Continue Up 20% YTD Biotech stocks were roughed up on Friday with a potential market rotation out of healthcare into technology. The XLK Technology SPDR was up 4% for the week compared to only 2% for the IBB. The XLK holds large cap stocks such as AAPL,MSFT,FB GOOG etc.The IBB is near […]

Continue Reading 0